Jamison Pike1, Alan Melnick2, Paul A Gastañaduy3, Meagan Kay4, Jeff Harbison2, Andrew J Leidner3, Samantha Rice5, Kennly Asato5, Linda Schwartz4, Chas DeBolt5. 1. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; jpike@cdc.gov. 2. Clark County Public Health, Vancouver, Washington. 3. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. 4. Public Health Seattle & King County, Seattle, Washington; and. 5. Washington State Department of Health, Olympia, Washington.
Abstract
BACKGROUND AND OBJECTIVES: Between December 31, 2018, and April 26, 2019, 72 confirmed cases of measles were identified in Clark County. Our objective was to estimate the economic burden of the measles outbreak from a societal perspective, including public health response costs as well as direct medical costs and productivity losses of affected individuals. METHODS: To estimate costs related to this outbreak from the societal perspective, 3 types of costs were collected or estimated: public health response (labor, material, and contractor costs used to contain the outbreak), direct medical (third party or patient out-of-pocket treatment costs of infected individuals), and productivity losses (costs of lost productivity due to illness, home isolation, quarantine, or informal caregiving). RESULTS: The overall societal cost of the 2019 Clark County measles outbreak was ∼$3.4 million ($47 479 per case or $814 per contact). The majority of the costs (∼$2.3 million) were incurred by the public health response to the outbreak, followed by productivity losses (∼$1.0 million) and direct medical costs (∼$76 000). CONCLUSIONS: Recent increases in incident measles cases in the United States and across the globe underscore the need to more fully understand the societal cost of measles cases and outbreaks and economic consequences of undervaccination. Our estimates can provide valuable inputs for policy makers and public health stakeholders as they consider budget determinations and the substantial value associated with increasing vaccine coverage and outbreak preparedness as well as the protection of society against vaccine-preventable diseases, such as measles, which are readily preventable with high vaccination coverage.
BACKGROUND AND OBJECTIVES: Between December 31, 2018, and April 26, 2019, 72 confirmed cases of measles were identified in Clark County. Our objective was to estimate the economic burden of the measles outbreak from a societal perspective, including public health response costs as well as direct medical costs and productivity losses of affected individuals. METHODS: To estimate costs related to this outbreak from the societal perspective, 3 types of costs were collected or estimated: public health response (labor, material, and contractor costs used to contain the outbreak), direct medical (third party or patient out-of-pocket treatment costs of infected individuals), and productivity losses (costs of lost productivity due to illness, home isolation, quarantine, or informal caregiving). RESULTS: The overall societal cost of the 2019 Clark County measles outbreak was ∼$3.4 million ($47 479 per case or $814 per contact). The majority of the costs (∼$2.3 million) were incurred by the public health response to the outbreak, followed by productivity losses (∼$1.0 million) and direct medical costs (∼$76 000). CONCLUSIONS: Recent increases in incident measles cases in the United States and across the globe underscore the need to more fully understand the societal cost of measles cases and outbreaks and economic consequences of undervaccination. Our estimates can provide valuable inputs for policy makers and public health stakeholders as they consider budget determinations and the substantial value associated with increasing vaccine coverage and outbreak preparedness as well as the protection of society against vaccine-preventable diseases, such as measles, which are readily preventable with high vaccination coverage.
Authors: Paul A Gastañaduy; Jeremy Budd; Nicholas Fisher; Susan B Redd; Jackie Fletcher; Julie Miller; Dwight J McFadden; Jennifer Rota; Paul A Rota; Carole Hickman; Brian Fowler; Lilith Tatham; Gregory S Wallace; Sietske de Fijter; Amy Parker Fiebelkorn; Mary DiOrio Journal: N Engl J Med Date: 2016-10-06 Impact factor: 91.245
Authors: Jennifer B Rosen; Robert J Arciuolo; Amina M Khawja; Jie Fu; Francesca R Giancotti; Jane R Zucker Journal: JAMA Pediatr Date: 2018-09-01 Impact factor: 16.193
Authors: Zuzana Špacírová; David Epstein; Leticia García-Mochón; Joan Rovira; Antonio Olry de Labry Lima; Jaime Espín Journal: Eur J Health Econ Date: 2020-01-20
Authors: Dominic Thorrington; Mary Ramsay; Albert Jan van Hoek; W John Edmunds; Roberto Vivancos; Antoaneta Bukasa; Ken Eames Journal: PLoS One Date: 2014-09-09 Impact factor: 3.240